Unknown OBSERVATIONAL NCT01315704

Alzheimer's Disease and Related Disorders (MERE)

Maladie d'Alzheimer et Maladies apparentées : Caractérisation Des Anomalies Cognitivo-motrices, et Des Effets Des médicaments Anti-démence et de la Vitamine D à Partir de la Mise en Place d'Une Base de données au CMRR du CHU d'Angers

Sponsor: University Hospital, Angers

Conditions Alzheimer's Disease Gait Apraxia Impaired Cognition

Interventions Drug intervention

Updated 7 times since 2017 Last updated: Mar 14, 2011 Started: Nov 30, 2009 Primary completion: Nov 30, 2017 Completion: Nov 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Alzheimer's Disease and Gait Apraxia and is currently ongoing. University Hospital, Angers leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 2 earlier versions

Feb 2018 — Apr 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting NA

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Angers

Data source: University Hospital, Angers

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Angers, France